Introduction
Retinoic acid (RA) is the most abundant metabolic product of vitamin A in vertebrates (Duester, 2008; Niederreither et al., 2002; Niederreither and Dolle, 2008; Theodosiou et al., 2010) . Normal development requires a proper balance of RA signaling, which is maintained through positive and negative feedback mechanisms (D'Aniello et al., 2013; Dobbs-McAuliffe et al., 2004; Lee et al., 2012; Niederreither et al., 1997; Reijntjes et al., 2005; Schilling et al., 2012; White et al., 2007) . The most robust feedback mechanism dictating RA levels within the embryo acts through controlling RA degradation (Reijntjes et al., 2005; White et al., 2007) . A conserved feature of RA signaling in vertebrate embryos is that increased RA induces expression of Cyp26a1 (Loudig et al., 2005; Pozzi et al., 2006) , which is the major embryonic RA degrading enzyme. Direct transcriptional activation through RA receptors (RARs) promotes the induction of cyp26a1 expression, which allows for it to rapidly respond to fluctuations in RA levels (Hu et al., 2008; Kashyap et al., 2013; Lalevee et al., 2011; Li et al., 2012; Loudig et al., 2000 Loudig et al., , 2005 . Although cyp26a1 is potentially the most sensitive gene that responds to modulation of RA within the early embryo due its direct transcriptional regulation (D'Aniello et al., 2013; Hu et al., 2008; Kashyap et al., 2013; Lalevee et al., 2011; Li et al., 2012; Loudig et al., 2005; Pozzi et al., 2006; White et al., 2007) , fluctuations of RA also affect the expression of the RA producing enzymes retinol dehydrogenase 10 (Rdh10), which generates the RA precursor retinal from retinol, and retinaldehyde dehydrogenase 1a2 (Aldh1a2), which generates RA from retinal (Dobbs-McAuliffe et al., 2004; Farjo et al., 2011) . In contrast to RA positively regulating Cyp26a1 expression, RA negatively regulates rdh10 and aldh1a2 expression (Dobbs-McAuliffe et al., 2004; Niederreither et al., 1997; Sandell et al., 2012; Sandell et al., 2007) . While the RA feedback mechanisms exist to help maintain RA signaling levels within an appropriate range, recent work has suggested that increases or decreases in RAR signaling can lead to complicated phenotypes that have aspects of defects observed in both gain and loss of RA signaling (Lee et al., 2012; Waxman and Yelon, 2011) . However, the mechanisms underlying these contradictory phenotypes are not yet completely understood. The location and control of Cyp26a1 expression are central to our understanding of how RA functions during vertebrate development. Within the early vertebrate embryo, RA acts as a morphogen creating a gradient that is required for patterning the anterior-posterior axis (Kudoh et al., 2002; Maves and Kimmel, 2005; White et al., 2007) . Recent studies have allowed the visualization of an RA gradient in zebrafish embryos (Shimozono et al., 2013; White et al., 2007) , but the mechanism underlying RA gradient formation in vertebrates has been highly debated. Models have been proposed where Cyp26a1 helps generate an RA gradient through cell-autonomous and cell non-autonomous mechanisms (Hernandez et al., 2007; Maves and Kimmel, 2005; Sirbu et al., 2005; Uehara et al., 2007; White et al., 2007; White and Schilling, 2008) . The strictly cell autonomous models proposed that the RA gradient is created through the differential expression and duration of Cyp26 enzymes within tissues (Hernandez et al., 2007; Maves and Kimmel, 2005; Sirbu et al., 2005) . This model is based on work examining hindbrain patterning in zebrafish and mice, which found that spatiotemporal differences in the location of Cyp26 enzymes correlates with the patterning of distinct rhombomeres (Hernandez et al., 2007; Maves and Kimmel, 2005; Sirbu et al., 2005) . In contrast to the strictly cell autonomous model, Uehara et al. (2007) first suggested Cyp26 enzymes may have cell non-autonomous consequences on RA signaling based on the observation that loss of Cyp26a1 and Cyp26c1 in the head mesenchyme leads to changes in the adjacent neuroectoderm. Similarly, in zebrafish, Martin and Kimelman (2010) found that Cyp26a1 does not have cell autonomous roles within mesodermal progenitor pool, suggesting non-autonomous functions. Furthermore, recent work from our lab has suggested that loss of Cyp26 enzymes can have cell non-autonomous consequences in patterning the cardiovascular progenitor fields within the anterior lateral plate mesoderm (Rydeen and Waxman, 2014) . Additionally, using computational modeling, White et al. (2007) proposed a model in zebrafish embryos where the embryonic RA gradient is shaped through self-enhanced degradation by promoting Cyp26a1 expression, in effect arguing that Cyp26a1 may have cell autonomous and cell non-autonomous consequences in shaping the embryonic RA gradient. Despite the arguments for and against Cyp26 enzymes being able to control RA levels in the environment, a direct test of cell non-autonomous effects of Cyp26 enzymes on RA levels within the embryo has not been performed.
Here, we sought to better understand the feedback mechanisms underlying the contradictory gain and loss of function phenotypes seen from teratogenic increases of RA signaling in vertebrate embryos and determine the cellular mechanisms that contribute to establishing the embryonic RA gradient. To do so, we employed a RA responsive hyperactive RAR, which induces contradictory phenotypes consistent with gain and loss of RA signaling (Waxman and Yelon, 2011) , similar to what is found with acute RA treatment in mice (Lee et al., 2012) . Importantly, we find that the loss of RA signaling within the early zebrafish embryo requires the rapid induction and persistent expression of Cyp26a1. Moreover, Cyp26a1 is required for the RA loss of function phenotypes, as cyp26a1/giraffe (gir) mutants injected with the hyperactive RAR do not display phenotypes consistent with loss of RA signaling. Importantly, we use the induction of Cyp26a1 in this model in combination with a transgenic RA sensor line to directly test the hypothesis that enhanced Cyp26a1 is required to affect the amount of RA in the local environment. Our studies are the first to directly demonstrate that Cyp26a1 can act as a sink that has cell non-autonomous consequences on local RA levels. Therefore, our work provides novel insight into the consequences of excessive embryonic RA signaling and the mechanisms that contribute to RA gradient formation.
Materials and methods

Zebrafish husbandry and transgenic lines
Zebrafish were raised and housed under standard conditions (Westerfield, 2000) . The following transgenic lines were used: Tg (-5.1myl7:DsRed-NLS) (Mably et al., 2003) , Tg(βactin:GDBD-RLBD); (UAS:EGFP) , Tg(βactin:GDBD-RLBD);(UAS: mCherry) and Tg(hsp70l:EGFP-VP-RAR). The cyp26a1/giraffe mutant was used (Emoto et al., 2005) .
mRNA synthesis
The cyp26a1 gene was cloned into pCS-DEST1 using the Tol2 Gateway kit (Invitrogen), as previously described (Villefranc et al., 2007) . Cyp26a1 mRNA was synthesized using the Sp6 Message Machine Transcription kit (Ambion).
mRNA and MO injections
All injections were performed at the one cell stage. 150 pg vprar mRNA was injected. The VP-RAR construct was reported previously as RARab-ΔAvp (Waxman and Yelon, 2011) . In this construct, the VP16 activation domain replaces the A terminal domain of the zebrafish RARab. 30 pg of membrane-rfp (mrfp) mRNA (Iioka et al., 2004) was injected into host embryos for transplantation experiments. Cyp26a1 mRNA was injected at 500 pg as previously described (Kudoh et al., 2002) . Previously published cyp26a1 MOs were injected using a cocktail of 2-4 ng cyp26a1 MO1 and 1-2 ng cyp26a1 MO2, as well as 3 ng p53 MO to combat non-specific cell death (D'Aniello et al., 2013; Rydeen and Waxman, 2014) .
In situ hybridization
Standard procedure was used for all whole mount ISH as described previously (Oxtoby and Jowett, 1993) . All probes were reported previously: cyp26a1 (ZDB-GENE-990415-44), rdh10a (ZDB-GENE-070112-2242), aldh1a2 (ZDB-GENE-001101-3), six6b (ZDB-GENE-050522-308), eng2a (ZDB-GENE-980526-167), egr2b (formerly krox20; ZDB-GENE-980526-283), myod1 (formerly myoD; ZDB-GENE-980526-561); hoxb5b (ZDB-GENE-000823-6), cyp26b1 (ZDB-GENE-030131-2908), cyp26c1 (ZDB-GENE-050714-2), nkx2.5 (ZDB-GENE-980526-321), egfp (accession number: JQ064510.1), and mCherry (accession number: JN795134.1). For experiments using the gir mutants, genotyping was done as described previously (Emoto et al., 2005) .
Reverse transcriptase quantitative PCR (RT-qPCR)
RT-qPCR was performed as has been previously described (D'Aniello et al., 2013; Rydeen and Waxman, 2014) . Whole embryo RNA was obtained from pooled groups of 30 embryos, which were homogenized in Trizol (Ambion) and isolated using Purelink RNA Microkit (Invitrogen). cDNA synthesis was performed with 1 mg RNA using the ThermoScript Reverse Transcriptase kit (Invitrogen). Quantitative real time PCR was performed with Power SYBR Green PCR Master Mix (Applied Biosystems) using standard PCR conditions in a BioRad CFX-96 PCR machine. Expression levels were standardized to β-actin expression and analyzed using the 2 À ΔΔCT Livak Method. Primer sequences for cyp26a1, rdh10a, aldh1a2, hoxb5b, amhc, vmhc, and myl7 are provided in Supplemental Table 1 .
Generation of Tg(hsp70l:EGFP-VP-RAR) ci104 line
The Tg(hsp70l:EGFP-VP-RAR) ci104 line was made using standard Tol2/gateway methods. The hsp70l promoter 5′-entry and polyA 3′-entry clones were used (Kwan et al., 2007) . For the middle entry clone, an EGFP N-terminal fusion was made to the VP-RAR construct using PCR, it was cloned into pCS2p þ , and mRNA was made. After confirming that this fusion protein retained fluorescence and functioned similarly to the native VP-RAR after mRNA injection at the one cell stage, the EGFP-VP-RAR fusion was cloned into a middle entry vector and then assembled into the previously reported pDestTol2p2A-αcry:Dsred destination vector ). Stable transgenic lines were then made and assayed for fluorescence and function after heat-shock. Multiple founders were identified that yielded the inducible transgene in a Mendelian ratio. The line selected for experiments yielded the brightest GFP expression after heat-shock.
Heat-shock experiments
Heat-shock experiments were performed using embryos obtained from hemizygous Tg(hsp70l:EGFP-VP-RAR) adults crossed to either hemizygous Tg(βactin:GDBD-RLBD);(UAS:mCherry) or WT adults. Embryos were maintained at 28.5°C until $ 24 hpf when they were heat-shocked at 37°C for 30 min in a BioRad PCR machine. Transgenic embryos were then sorted from their nontransgenic siblings by the presence of GFP.
Cell counts
Immunohistochemistry, cell counts, and statistical analysis were performed as previously described (Waxman et al., 2008) .
Blastula transplantation experiments
Transplantation experiments were performed similar to what has been previously described (Waxman et al., 2008) . For all experiments Tg(βactin:GDBD-RLBD);(UAS:EGFP) donor embryos were injected with 1 ng Cascade Blue-dextran tracer (Life Technologies). Amounts of cyp26a1 MOs, mrfp and vp-rar mRNAs are indicated in Table 1 . Embryos were chemically dechorionated using Pronase (Sigma). At sphere stage, approximately 30 cells from donor embryos were transplanted into the marginal zone of host embryos. Following transplantation, host and donor embryos were transferred to 24 well dishes with one embryo per well and maintained at 28.5°C. Donors were maintained to confirm the potential of the donor RA sensor cells to respond to RA. At 20 hpf, host embryos were screened for donor cell contribution and GFP expression, then imaged using a Nikon A1 confocal microscope. Statistics were performed using a chi-squared test where p o0.05 was considered statistically significant. (Q,R) ISH using a six6b (anterior diencephalon), eng2a (midbrain-hindbrain boundary), egr2b (rhombomeres 3 and 5), and myod1 (adaxial cells and somites) cocktail (referred to here at sekm cktl) shows a lack of eng2a and severely reduced six6b and rhombomere 3 (anterior egr2b) in vp-rar mRNA injected compared to WT. Arrows in R indicate the loss of eng2a and reduced rhombomere 3. (S,T) Expression of hoxb5b is decreased in the lateral plate mesoderm (brackets) and anterior spinal cord (arrows) in vp-rar mRNA injected embryos compared to WT siblings. (U) RT-qPCR with cyp26a1, rdh10a, aldh1a2, and hoxb5b expression in vp-rar mRNA injected embryos at the shield (sh) through 24 s stages. Asterisks indicate statistically different from control (p o0.05) using Student's t-test.
Results
A hyperactive RAR can induce both increases and decreases in RA signaling
Previous studies have indicated that increases in RA signaling can induce overtly contradictory phenotypes. Our previous work using a RA dependent hyperactive RAR (VP-RAR) can induce both gain and loss of RA signaling phenotypes (Waxman and Yelon, 2011) , similar to a pulsed RA treatment in mice (Lee et al., 2012) , but the mechanisms underlying how enhanced RA signaling produces these seemingly contradictory phenotypes are not completely understood. To determine if inappropriate modulation of RA metabolizing enzyme expression underlies both gain and loss of RA signaling phenotypes in zebrafish embryos, we injected zebrafish embryos at the one-cell stage with vp-rar mRNA and assayed the expression of the major embryonic RA producing enzymes rdh10a and aldh1a2 and the RA degrading enzyme cyp26a1. We found by in situ hybridization (ISH) that vp-rar mRNA-injected embryos had a rapid and maintained early global induction of cyp26a1 expression (Fig. 1A-D) . The increased expression of cyp26a1 in vp-rar mRNA-injected embryos was overtly detectable by in situ hybridization (ISH) through the 14 somite (s) stage ( Fig. 1E-H) . Assaying cyp26a1 expression with RT-qPCR demonstrated a dramatic induction by the shield stage, which gradually attenuates by 24 h post-fertlization (hpf) (Fig. 1U) . In contrast to the effects on cyp26a1, injection of vp-rar mRNA produced a reduction in the expression domains of the RA synthesizing enzymes rdh10a and aldh1a2 by the tailbud stage ( Fig. 1I-P) . RT-qPCR indicated that aldh1a2 expression was decreased by the shield (sh) stage, while the expression of both rdh10a and aldh1a2 was decreased by the tailbud (tb) stage and then gradually attenuated to normal by 16 s (Fig. 1U) . Together, these data indicate that enhancing the endogenous RA signaling with the hyperactive RAR can produce two effects on the expression of the RA metabolizing machinery: first, a dramatic, rapid and prolonged induction of cyp26a1; second, a slightly more delayed and more transient repression of the expression of RA producing enzymes.
In vertebrates, early increases in RA signaling lead to reduction of head size and anterior hindbrain along with loss of the midbrain hindbrain boundary (MHB) (Hernandez et al., 2007; Waxman and Yelon, 2011; White et al., 2007; White and Schilling, 2008) . We found that vp-rar mRNA injected embryos exhibited smaller head size and loss of the MHB (Fig. 1Q, R) , consistent with increases in RA signaling. However, in contrast with the effects observed on the brain, vp-rar mRNA injected embryos also had loss of hoxb5b (Fig. 1S, T) , a direct target of RA that initiates later (D'Aniello et al., 2013; Waxman et al., 2008) , which is a phenotype indicative of decreased RA signaling. Moreover, decreased hoxb5b expression persisted through the 20 s stage (Fig. 1S, T, U) . Therefore, our data suggest that enhancing RA signaling with the hyperactive RAR promotes a rapid conversion from increased RA signaling to decreased RA signaling along the anterior-posterior axis of the embryos.
To better understand the consequences of the transition from increased to decreased RA signaling, we examined cardiomyocyte development. Increases in RA signaling can inhibit cardiomyocyte specification, while decreases in RA signaling can promote cardiomyocyte specification (Keegan et al., 2005; Rydeen and Waxman, 2014; Waxman and Yelon, 2009 ). Interestingly, examining heart morphology, cell number, and cardiomyocyte marker expression, we found that the hearts of vp-rar mRNA-injected Tg(-5.1myl7:DsRed-NLS) f2 embryos (Mably et al., 2003) were enlarged, had increased cell number, and increased cardiomyocyte marker expression at 48 hpf ( Fig. 2A-D) , which are all phenotypes associated with loss of RA signaling (Waxman et al., 2008) .
Therefore, these results suggest that vp-rar mRNA injection promotes defects from inverse levels of RA signaling: first, it promotes early teratogenic increases in RA signaling that inhibit anterior brain development; second, slightly later specified, more-posterior tissues, including the cardiac progenitors, sense there is a loss of RA signaling.
3.2. Cyp26a1 is necessary to produce a loss of RA signaling after enhanced RA signaling
Since we found that there was a strong induction of cyp26a1 expression coupled with a loss of RA producing enzymes, we next wanted to determine if the loss of RA signaling was due to a loss of embryonic RA. To do this, we used our recently reported transgenic RA sensor line, Tg(βactin:GDBD-RLBD);(UAS:EGFP) , which employs a ubiquitously expressed Gal4 DNA binding domain fused to a RAR ligand binding domain to drive UAS:EGFP in the presence of RA. Tg(βactin2:GDBD-RLBD);(UAS: EGFP) embryos injected with vp-rar mRNA had dramatically reduced egfp expression compared to WT siblings (Fig. 3A, B) . To determine if this feedback mechanism is also sufficient to produce a reduction in embryonic RA at later stages of development, we created a heat-shock inducible vp-rar transgenic lineTg(hsp70l:EGFP-VP-RAR) ci104 (Supplemental Fig. 1 ). Heat-shocking the Tg(hsp70l:EGFP-VP-RAR) line at 26 hpf enhances cyp26a1 and represses rdh10a by 4 h post-heat shock similar to what we observed at earlier stages (Supplemental Fig. 2) . To examine the effects on embryonic RA, hemizygous Tg(hsp70l:EGFP-VP-RAR) fish were crossed with hemizygous (βactin:GDBD-RLBD);(UAS:mCherry) fish. Embryos were then selected for mCherry expression prior to heat-shock at 24 hpf. Consistent with injection of the vp-rar mRNA, we found that heat-shocked Tg(hs70l:EGFP-VP-RAR); (βac-tin:GDBD-RLBD);(UAS:mCherry) embryos had visibly less mCherry expression by four hours after heat-shock (Fig. 3C, D) , suggesting a rapid turnover and loss of RA signaling. Therefore, our results show that enhanced RAR transcriptional activity that initially results in enhanced RA signaling subsequently produces loss of embryonic RA. We next wanted to understand what was causing the loss of embryonic RA. We reasoned that the loss could be caused by the increased Cyp26a1, decreased Rdh10a and Aldh1a2, or the combined effects on these enzymes. However, since we observed a more dramatic and prolonged increase in cyp26a1 expression after enhancing RA signaling with the hyperactive RAR, we focused on the hypothesis that increased Cyp26a1 is required to deplete the embryonic RA. To test this hypothesis, we injected vp-rar mRNA into embryos from heterozygous cyp26a1/gir mutant adult crosses (Emoto et al., 2005) and examined hoxb5b expression. We found that gir mutants injected with vp-rar mRNA had an expansion of hoxb5b expression, similar to uninjected siblings (Fig. 4A-D) , indicating that Cyp26a1 induction contributes to the loss of RA signaling phenotype. To further corroborate this hypothesis, we examined if the increased heart size, due to an increase in cardiomyocyte specification, was also dependent on cyp26a1 expression. Consistent with the effect on hoxb5b expression, we found that gir mutants injected with vp-rar mRNA did not exhibit an increase in the expression of the cardiomyocyte marker nkx2.5, which was found in vp-rar mRNA injected WT siblings (Fig. 5A-E) , suggesting that increased cardiomyocyte specification is Cyp26a1 dependent. However, cyp26a1 deficiency in vp-rar mRNA injected embryos failed to rescue anterior brain defects and did not result in positive or negative effects on rdh10a expression at these later stages (Fig. 4E-H) , suggesting that the early anterior RA gain-offunction phenotype induced by the enhanced RA signaling is epistatic to Cyp26a1 function. To determine if increased cyp26a1 expression alone is sufficient to produce a loss of RA signaling phenotypes comparable to what we observe with vp-rar mRNA injection, we injected cyp26a1 mRNA at previously reported doses (Kudoh et al., 2002) . However, we did not observe phenotypes at any stages that were indicative of a strong loss of RA signaling or effects on the RA sensor line Tg(βactin:GDBD-RLBD);(UAS:EGFP) at 24 hpf (Supplemental Fig. 3) . While RA signaling levels were not strongly affected, expression of the RA synthesizing enzymes rdh10a and aldh1a2 were increased in Cyp26a1 overexpressing embryos (Supplemental Fig. 3 ), suggesting the enhanced expression of Cyp26a1 alone initiates compensatory feedback that prevents a significant loss in RA signaling. Altogether, these results indicate that Cyp26a1 is necessary, but not alone sufficient, for the loss of embryonic RA signaling that follows enhanced RA signaling.
Modulation of Cyp26a1 can have cell non-autonomous effects on RA levels
The mechanism by which Cyp26 enzymes control RA in the environment has been disputed for many years (Hernandez et al., 2007; Sirbu et al., 2005; White et al., 2007; White and Schilling, 2008) . Although Cyp26 enzymes are believed to act as a sink for RA, evidence supporting or refuting a strictly cell autonomous role in development has yet to be directly tested. Because our results suggest that increased cyp26a1 expression is required after excess RA signaling to create a deficiency of embryonic RA, we wanted to exploit this observation and determined if Cyp26a1 can have cell non-autonomous effects on RA levels within the local environment. We first performed blastula transplantation experiments using Tg(βactin:GDBD-RLBD);(UAS:EGFP) RA sensor embryos as donors and WT or vp-rar mRNA injected embryos as hosts. We found that RA sensor donor cells transplanted into WT hosts consistently exhibited robust GFP expression when donor cells gave rise to notochord or neural tissue in the trunk ( Fig. 6A-A3 , C-C3, E). Conversely, RA sensor donor cells transplanted into vp-rar mRNA-injected hosts had dramatically dampened or absent GFP expression, despite giving rise to notochord or neural tissue in a region of the embryo that would normally express GFP (Fig. 6B-B3, D-D3, E) , which suggests the vp-rar expression can promote cell non-autonomous loss of RA signaling. Next, to determine if the cell non-autonomous effects of vp-rar expression were dependent on Cyp26a1, we transplanted RA sensor donor cells into WT hosts or hosts co-injected with vp-rar mRNA and previously characterized cyp26a1 MOs (D' Aniello et al., 2013; Rydeen and Waxman, 2014) . In contrast to when RA sensor cells were transplanted into vp-rar mRNA injected hosts, we found that depletion of Cyp26a1 in vp-rar mRNA injected host embryos results in RA sensor donor cells with robust GFP expression ( Fig. 6E and Supplemental Fig. 4) . A series of control experiments also demonstrated that RA sensor donors transplanted into Cyp26a1 deficient host embryos have GFP expression, as would be predicted (Fig. 6E and Supplemental  Fig. 5) . Lastly, to exclude the possibility that cyp26a1 expression was being induced cell non-autonomously in the RA sensor donor cells when transplanted into vp-rar mRNA injected hosts, we transplanted Cyp26a1 deficient RA sensor donor cells into either WT or vp-rar mRNA injected hosts. We found that Cyp26a1 deficient donor cells transplanted into vp-rar mRNA injected hosts lacked GFP expression ( Fig.6E and Supplemental Fig. 6 ). Altogether, our data suggest that Cyp26a1 can act as a sink and have cell non-autonomous consequences on the amount of RA in the local environment.
Discussion
In this paper, we examined two fundamental aspects of embryonic RA signaling in vertebrates. First, we examined how teratogenic levels of RA signaling promote feedback gain-and lossof-function phenotypes in vertebrates. In zebrafish embryos, we found that enhancing RA signaling, using an RA-responsive hyperactive RAR to bolster the signaling from endogenous RA, initiated a seemingly straightforward feedback mechanism that dramatically induced Cyp26a1, which in turn is required to cause loss of RA signaling phenotypes due to the depletion of embryonic RA. Second, we found that in this context Cyp26a1 is required for cell non-autonomous loss of RA in the local environment, presumably through acting a sink for RA that limits the amount of RA exposure to neighboring cells.
We have explicitly examined a mechanism underlying how teratogenic levels of RA signaling can lead to contradictory phenotypes indicative of both gain and loss of RA signaling. While previous studies found RA supplementation after the initial pulse of RA to the mother was able to partially restore improper kidney specification in mouse embryos (Lee et al., 2012) , the effectors that cause the loss of RA signaling in the mouse embryo under these conditions were not specifically determined. Our data are consistent with a model where temporal differences in embryonic patterning are affected by converse fluctuations in RA signaling. We infer that injecting or inducing the hyperactive RAR results in bursts of enhanced RA signaling, similar to teratogenic pulses of RA treatment in mouse embryos (Waxman and Yelon, 2011) , which initiates early RA responsive genes. Furthermore, since more anterior tissues are specified first, loss of midbrain and anterior hindbrain specification is consistent with effects from an initial increase in RA signaling (Cai et al., 2012; Hernandez et al., 2007; Maves and Kimmel, 2005; White and Schilling, 2008) . However, the initial burst of RA signaling also induces excessive negative feedback that turns off RA signaling in the subsequently patterned, adjacent posterior tissues, which is reflected in phenotypes including increased cardiomyocyte specification and loss of hoxb5b expression. Together, these finding suggest that the increased RA signaling is rapidly sequestered and metabolized between patterning of the hindbrain and the cardiac field to yield opposing phenotypes. Similarly, in the RA treated mice, loss of function defects were observed in the more posterior structures such as the kidneys (Lee et al., 2012) . It is tempting to speculate that our results demonstrate the increased cyp26a1 expression as a result of enhanced RA signaling is potentially the sole mechanism responsible for the loss of RA signaling. However, overexpression of cyp26a1 mRNA in zebrafish embryos elicits relatively modest effects on patterning. The simplest interpretation of this result is that increased Cyp26a1 is required for the loss of RA signaling, but is not sufficient alone to elicit a clearing and loss of RA signaling. One possibility is that the repression of rdh10a and aldh1a2 expression sensitizes embryos to increased Cyp26a1 expression. Alternatively, Cyp26a1 may be the primary contributor to a loss of RA signaling, but overexpression of cyp26a1 mRNA alone cannot fully recapitulate the temporal cascade initiated from excess RA signaling or it initiates feedback that compensates for the loss of RA.
Despite the overtly conserved phenotypic trends in response to enhanced RA signaling in vertebrate embryos, the temporal responses of RA metabolic machinery expression in zebrafish contrast somewhat with what was reported in the mouse. It was found that a single dose of RA in the mouse can lead to transient increases in Cyp26 enzymes but prolonged decreases in Aldh1a2 expression (Lee et al., 2012) . In contrast to what was found in the mouse, we observed that there was prolonged cyp26a1 expression and more transient loss of RA producing enzyme expression in zebrafish embryos. One reason for the differences in transcriptional response of the expression of RA metabolic machinery between species may be explained by the differing techniques used to transiently increase RA signaling. However, we do not presently think this is the case as cyp26a1, aldh1a2, and rdh10a expression respond similarly to RA treatment (D'Aniello et al., 2013; Feng et al., 2010) . Another possible reason for the observed differences is the developmental stages of the RA signaling insult. In Lee et al. (2012) , a singular RA treatment was given to a pregnant dam when the embryos were at E9.0. The RA feedback response was then measured in the embryos at E9.5 through E12.0. Here, we primarily examined the effects after injection of zebrafish embryos at the 1-cell stage with hyperactive rar mRNA and measured the response over the first 24 h of development. Therefore, the murine embryos received the teratogenic RA signaling at a comparably later developmental stage. While we found that embryos with heat-shock induced vp-rar expression beginning at 24 hpf, a time point comparable to murine E9.0, had a loss of embryonic RA similar to injection earlier, we did not determine if the temporal responses of the RA metabolic machinery are different than earlier stages over a long period of time. It is also plausible that perhaps the temporal responses of the RA metabolic machinery to enhanced RA have changed in response to inherent differences in mammalian and teleost embryos, such as the rate of development. Although previous work has demonstrated that the dynamic responsiveness of cyp26a1 to RA in vertebrates is conveyed through co-operativity between 3 conserved RAREs within the cyp26a1 promoter (Hu et al., 2008; Li et al., 2012; Loudig et al., 2000 Loudig et al., , 2005 , changes in the cyp26a1 promoters that account for temporal differences in responsiveness between vertebrates have not been investigated. Therefore, although teratogenic levels of RA signaling may elicit slightly different temporal responses of RA metabolic machinery expression in vertebrate embryos, our results suggest that the feedback ultimately leads to congenital defects from a loss of embryonic RA signaling.
Our results also have implications for how RA gradients are formed within vertebrate embryos. Although Cyp26 enzymes are necessary for negative feedback believed to play a role in shaping the embryonic RA gradient (Cai et al., 2012; White et al., 2007; White and Schilling, 2008) , the cellular mechanism by which Cyp26 enzymes control RA in the local environment has been greatly debated. There have been two prevailing models for how Cyp26 enzymes functions to shape the RA gradient. First, Cyp26 enzymes play strictly cell autonomous roles that limit cellular RA levels and RA signaling. Second, Cyp26 enzymes have cell autonomous and cell non-autonomous consequences on RA levels and signaling that shape the gradient. Recent studies from our lab and others have suggested that loss of Cyp26 enzymes may lead to increased RA signaling in neighboring cells (Rydeen and Waxman, 2014; White et al., 2007) . However, until now there has been no direct evidence supporting or refuting a strictly cell autonomous role of Cyp26 expression in controlling embryonic RA signaling. Thus, our blastula transplantation experiments incorporating transgenic RA sensor lines provide the first direct evidence that Cyp26 enzymes is required to as a sink that removes RA from the local environment, limiting the amount of RA signaling exposure to neighboring cells. Altogether, our data suggest that modulation of Cyp26 enzyme expression can have cell non-autonomous consequences on RA signaling within neighboring tissues, which provide support for a model where dynamic Cyp26a1 expression helps to shape the embryonic RA gradient through rapid RA-responsive fluctuations (White et al., 2007) .
In conclusion, our study enhances our understanding of how RA feedback mechanisms respond to fluctuation in RA signaling levels and can adversely affect vertebrate development. These findings will potentially have implications for developing new strategies aimed at preventing defects found in RA embryopathies and other disease contexts where there is dysregulation of RA signaling through modulation of Cyp26 activity.
